pvx-410
Showing 1 - 4 of 4
Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pembrolizumab, PVX-410)
Active, not recruiting
- Triple Negative Breast Cancer
- Metastatic Breast Cancer
- Pembrolizumab
- PVX-410
-
Boston, Massachusetts
- +2 more
Dec 21, 2022
Metastatic Triple-Negative Breast Carcinoma Trial (PVX-410)
Not yet recruiting
- Metastatic Triple-Negative Breast Carcinoma
- PVX-410
- (no location specified)
Apr 18, 2022
Breast Cancer Trial in Tampa, Boston, New York (PVX-410, Durvalumab, Hiltonol)
Active, not recruiting
- Breast Cancer
- PVX-410
- +2 more
-
Tampa, Florida
- +4 more
May 7, 2021